tiprankstipranks
Trending News
More News >
Gland Pharma Ltd. (IN:GLAND)
:GLAND
India Market

Gland Pharma Ltd. (GLAND) Income Statement

Compare
0 Followers

Gland Pharma Ltd. Income Statement

Last quarter (Q4 2025), Gland Pharma Ltd.'s total revenue was ₹14.25B, a decrease of -7.32% from the same quarter last year. In Q4, Gland Pharma Ltd.'s net income was ₹1.87B. See Gland Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 56.17B₹ 56.42B₹ 36.25B₹ 43.84B₹ 34.24B
Gross Profit
₹ 33.27B₹ 30.88B₹ 19.39B₹ 22.75B₹ 19.32B
Operating Expenses
₹ 15.94B₹ 14.66B₹ 10.61B₹ 8.75B₹ 7.28B
Depreciation and Amortization
₹ 3.78B₹ 3.45B₹ 1.47B₹ 1.10B₹ 987.80M
EBITDA
₹ 12.69B₹ 15.03B₹ 12.09B₹ 17.34B₹ 14.37B
Operating Income
₹ 17.33B₹ 16.45B₹ 8.84B₹ 14.00B₹ 12.03B
Other Income/Expenses
₹ -6.71B₹ -5.13B₹ -1.02B₹ 2.18B₹ -839.40M
Pretax Income
₹ 10.63B₹ 11.33B₹ 10.55B₹ 16.19B₹ 13.35B
Net Income
₹ 6.99B₹ 7.72B₹ 7.81B₹ 12.12B₹ 9.97B
Per Share Metrics
Basic EPS
₹ 42.40₹ 46.90₹ 47.44₹ 73.81₹ 63.07
Diluted EPS
₹ 42.40₹ 46.89₹ 47.43₹ 73.64₹ 62.99
Weighted Average Shares Outstanding
164.75M 164.70M 164.64M 164.15M 158.08M
Weighted Average Shares Outstanding (Diluted)
164.75M 164.73M 164.68M 164.54M 158.28M
Currency in INR

Gland Pharma Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis